Israeli-based digital health technology company GrayMatters Health, which develops self-neuromodulation therapies for mental disorders, received FDA 510(k) clearance for its PTSD-focused neuromodulation therapy dubbed Prism. The company uses a proprietary model to create a unique…
Continue Reading
Digital health technology company NeuroRPM has received FDA 510(k) clearance for its AI-enabled remote monitoring app that utilizes an Apple Watch to track common Parkinson’s symptoms such as bradykinesia, tremor and dyskinesia.Bradykinesia is slowness…
Continue Reading
What You Should Know:– Abbott today released the latest installment in the company’s multi-year Beyond Intervention series of global healthcare market research designed to uncover challenges that arise within the patient journey of people living with cardiovascular disease and to identify…
Continue Reading
The Medical Software Industry Association has called on the Medical Board of Australia to think twice about imposing changes to telehealth rules, saying there could be “serious unintended” consequences.In a statement, the peak organisation…
Continue Reading
Randy K. Hawkins, M.D., Chief Medical Officer at TranscarentTranscarent appoints Dr. Randy Hawkins as Chief Medical Officer (CMO) and will report to Transcarent Chief Executive Officer, Glen Tullman. As CMO, Dr. Hawkins will oversee…
Continue Reading
